20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T13572 | Cancer-Targeting Compound 1 | Others | |
Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among othe... | |||
T13491 | Neuromuscular-targeting compound 1 | Others | |
Neuromuscular-targeting compound 1 can be used to study muscular dystrophy and neuromuscular-related diseases. | |||
T13573 | Arrhythmias-Targeting Compound 1 | Others | |
Arrhythmias-Targeting Compound 1 is a compound. It is used in the research of arrhythmias. | |||
T13900 | Arrhythmic-Targeting Compound 1 | Others | |
Arrhythmic-Targeting Compound 1 is used for arrhythmic disease, with nitrogen-containing spirocycles. | |||
T10071 | Itch-Targeting Compound 1 | Others | |
Itch-Targeting Compound 1 is an anti-itch compound. It is effective in preventing or treating reactions on insect's bites, reactions on environmental allergens, skin infections, external vermination, or itches occurring ... | |||
T19417 | Urinary Incontinence-Targeting Compound 1 | Others | |
Urinary Incontinence-Targeting Compound 1, used in the research of urinary incontinence, is a sulfonanilide derivative. | |||
T13486 | Neurodegenerative Disorder-Targeting Compound 1 | Others | |
Neurodegenerative Disorder-Targeting Compound 1 is an inhibitor of calpain [1]. | |||
T10059 | Neuromuscular Disorder-Targeting Compound 1 | Others | |
Neuromuscular Disorder-Targeting Compound 1 is a compound used in the research of neuromuscular disorders, for example, symptoms of chronic fatigue syndrome and fibromyalgia syndrome. | |||
T83724 | TPP-1 hydrochloride | Targeting PD-L1 Peptide | |
TPP-1, a peptide inhibitor, targets the interaction between programmed cell death protein 1 (PD-1) and its ligand (PD-L1), binding specifically to PD-L1 with a dissociation constant (Kd) of 94.67 nM. At a concentration o... | |||
T83857 | Soluble Epoxide Hydrolase PROTAC 1a | sEH Proteolysis-targeting Chimera 1a,Soluble Epoxide Hydrolase Proteolysis-targeting Chimera 1a,sEH PROTAC 1a | |
Soluble epoxide hydrolase (sEH) PROTAC 1a is a proteolysis-targeting chimera (PROTAC) comprising a cereblon ligand linked to the sEH inhibitor t-TUCB via a linker, promoting selective sEH degradation and inhibiting its h... | |||
T83527 | (Rac)-Neurodegenerative Disorder-Targeting Compound 1 | ||
(Rac)-Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor. | |||
T76218 | Targeting the bacterial sliding clamp peptide 46 | ||
Peptide 46 is a short peptide that inhibits SC-dependent DNA synthesis by targeting the bacterial sliding clamp (SC). | |||
T60015 | TSPO ligand-2 | Carbonic acid | AUTACs |
TSPO ligand-2 (Carbonic acid) is a ligand of AUTAC1 which contains a p-fluorobenzylguanine and a Fumagillol moiety. | |||
T22282 | Brr2-IN-3 | Brr2 Inhibitor 9,Brr2 Inhibitor C9 | Others |
Brr2-IN-3 (Brr2 Inhibitor C9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders). | |||
T11249L | Dxd | Exatecan derivative for ADC,OQM5SD32BQ,UNII-OQM5SD32BQ | Topoisomerase |
Dxd (OQM5SD32BQ) is a potent inhibitor of DNA topoisomerase I with an IC50 of 0.31 μM. It is used as a conjugated drug of HER2-targeting ADC. | |||
T18893 | 5(6)-Carboxyfluorescein | 5-(and-6)-Carboxyfluorescein mixed isomers,5(6)-FAM | Others |
5(6)-Carboxyfluorescein (5-(and-6)-Carboxyfluorescein mixed isomers) contains a carboxylic acid that can be used to react with primary amines via carbodiimide activation of the carboxylic acid. | |||
T6804 | Chetomin | Chaetomin,NSC289491,BRN0077366 | Apoptosis , HSP , HIF |
Chetomin (BRN0077366) is an inhibitor of HIF-1 by weaken transcription of HIF-1, disrupting the binding of HIF-1α and HIF-2α to p300 at low nanomolar concentrations. | |||
T10531 | BGB-102 | JNJ-26483327 | EGFR , VEGFR , FLT , Src |
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders an... | |||
T60075 | Dopamine D2 receptor agonist-2 | Dopamine D2 Receptor | Dopamine Receptor |
Dopamine D2 receptor agonist-2 (Dopamine D2 Receptor) is a ligand targeting the dopamine D2 receptor. | |||
T39370 | Tri-GalNAc-COOH | LYTACs | |
Tri-GalNAc-COOH is a ligand for the asialoglycoprotein receptor (ASGPR) commonly employed in Lysosome Targeting Chimera (LYTAC) investigations. |